0001144204-15-011504.txt : 20150223 0001144204-15-011504.hdr.sgml : 20150223 20150223174151 ACCESSION NUMBER: 0001144204-15-011504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150219 FILED AS OF DATE: 20150223 DATE AS OF CHANGE: 20150223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 781-788-9043 MAIL ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ventech Capital II CENTRAL INDEX KEY: 0001604072 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 15641128 BUSINESS ADDRESS: STREET 1: 47 AVENUE DE L?OPERA CITY: PARIS STATE: I0 ZIP: 75002 BUSINESS PHONE: 01-83-79-81-91 MAIL ADDRESS: STREET 1: 47 AVENUE DE L?OPERA CITY: PARIS STATE: I0 ZIP: 75002 4 1 v402183_4.xml OWNERSHIP DOCUMENT X0306 4 2015-02-19 0 0001372514 EYEGATE PHARMACEUTICALS INC EYEG 0001604072 Ventech Capital II 47 AVENUE DE L'OPERA PARIS CEDEX 07 I0 75002 FRANCE 0 0 1 0 Common Stock 2015-02-19 4 C 0 506563 A 506563 D Common Stock 2015-02-19 4 C 0 142218 A 648781 D Common Stock 2015-02-19 4 C 0 501405 A 1150186 D Common Stock 2015-02-19 4 C 0 241270 4.20 A 1391456 D Common Stock 2015-02-19 4 P 0 102777 6.00 A 1494233 D Series B Preferred Stock 2015-02-19 4 C 0 11801 0 D Common Stock 11801 0 D Series C Preferred Stock 2015-02-19 4 C 0 17363 0 D Common Stock 17363 0 D Series D Preferred Stock 2015-02-19 4 C 0 140685 0 D Common Stock 140685 0 D Convertible Promissory Note 4.20 2015-02-19 4 P 0 1013334 1013334 A 2015-02-19 2015-06-06 Common Stock 241270 1013334 D Convertible Promissory Note 4.20 2015-02-19 4 C 0 1013334 0 D 2015-02-19 2015-06-06 Common Stock 241270 0 D Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of Common Stock of the Issuer on a 10.94-for-one basis, and had no expiration date. Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of Common Stock of the Issuer on a 9.60-for-one basis, and had no expiration date. Upon closing of the Issuer's initial public offering, each share of Series D Preferred Stock converted automatically into shares of Common Stock of the Issuer on a 10.96-for-one basis, and had no expiration date. *Signed under power of attorney on behalf of Reporting Person /s/ Alain Caffi, Chairman of Managing Board* 2015-02-23